Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells

Autor: Egbert K. O. Kruithof, Sylvie Dunoyer-Geindre
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Tissue Plasminogen Activator/biosynthesis/genetics
RNA
Messenger/genetics/metabolism

Physiology
Histones/metabolism
030204 cardiovascular system & hematology
Epigenesis
Genetic/drug effects

Histone Deacetylases
Epigenesis
Genetic

Histones
03 medical and health sciences
0302 clinical medicine
Physiology (medical)
Humans
RNA
Messenger

Epigenetics
Promoter Regions
Genetic

Cells
Cultured

DNA Primers
030304 developmental biology
ddc:616
DNA Primers/genetics
0303 health sciences
Base Sequence
biology
T-plasminogen activator
Hepatocytes/metabolism
Endothelial Cells
DNA Methylation
Molecular biology
Histone Deacetylase Inhibitors
Endothelial Cells/drug effects/metabolism
Histone
PCAF
Acetylation
Tissue Plasminogen Activator
DNA methylation
Hepatocytes
biology.protein
Histone Deacetylases/metabolism
Histone deacetylase
Cardiology and Cardiovascular Medicine
Plasminogen activator
Histone Deacetylase Inhibitors/pharmacology
Zdroj: Cardiovascular Research, Vol. 90, No 3 (2011) pp. 457-63
Cardiovascular research
ISSN: 0008-6363
Popis: Aims Tissue-type plasminogen activator (t-PA) is produced by endothelial cells (EC) and is responsible for the removal of intravascular fibrin deposits. We investigated whether expression of t-PA by EC is under epigenetic control. Methods and results Methylation analysis of the proximal t-PA promoter revealed a stretch of unmethylated CpG dinucleotides from position −121 to +59, while upstream CpG dinucleotides were all methylated. In contrast, in human primary hepatocytes, which express t-PA at much lower levels than EC, the proximal promoter was partially methylated. Treatment of EC with the non-specific histone deacetylase (HDAC) inhibitors butyrate and trichostatin and with MS275, a specific inhibitor of class I HDAC, resulted in a time- and dose-dependent increase in t-PA expression. Garcinol and anacardic acid, inhibitors of the histone acetyl transferases CBP/p300 and PCAF, reduced basal and HDAC inhibitor-induced t-PA expression, whereas curcumin, an inhibitor of CBP/p300 only, had no effect. We performed chromosome immunoprecipitation analysis of the t-PA promoter using antibodies specific for acetylated histone H3 or H4 and observed an increase in H3 acetylation of 10 ± 3 and 44 ± 14-fold in EC treated with trichostatin or MS275, respectively, and in H4 acetylation of 7.7 ± 1.4 and 16 ± 3-fold, respectively. Conclusion The proximal t-PA promoter is unmethylated in human EC and partially methylated in human primary hepatocytes. Expression of t-PA by EC is repressed by HDACs in a mechanism that involves de-acetylation of histone H3 and H4
Databáze: OpenAIRE